{"id":30809,"date":"2025-03-28T11:20:45","date_gmt":"2025-03-28T03:20:45","guid":{"rendered":"https:\/\/flcube.com\/?p=30809"},"modified":"2025-03-28T11:20:46","modified_gmt":"2025-03-28T03:20:46","slug":"microport-medbot-reports-strong-2024-growth-for-toumai-and-skywalker-robots","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30809","title":{"rendered":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots"},"content":{"rendered":"\n

Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252<\/a>) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.<\/p>\n\n\n\n

Toumai Robot’s Market Expansion<\/strong>
In 2024, the Toumai robot achieved 39 new global orders with over 30 commercial installations. As of now, cumulative commercial orders worldwide exceed 60. In China, its market share continued to rise, capturing over 60% in provincial top Class 3A hospitals and national top 100 hospitals. Internationally, the product expanded into emerging markets in Asia, Africa, and Latin America within just one year and achieved breakthroughs in the high-end European market, securing over 20 commercial orders.<\/p>\n\n\n\n

SkyWalker Robot’s Global Synergy<\/strong>
SkyWalker leveraged its synergy with parent company MicroPort Scientific Corp. (HKG: 0853<\/a>), achieving significant YOY growth in installed capacity, with a total of over 40 global orders. These orders covered medical institutions across five continents, including China, the United States, Germany, Italy, Belgium, Greece, Australia, and Brazil. Leading in domestic orthopedic surgical robot globalization, SkyWalker has assisted in nearly 2000 total knee replacement surgeries to date.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257…<\/p>\n","protected":false},"author":1,"featured_media":30810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[27,982,1279,814,192],"class_list":["post-30809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-finanical-reports","tag-hkg-0853","tag-hkg-2252","tag-microport-medbot","tag-microport-scientific"],"yoast_head":"\nMicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30809\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots\" \/>\n<meta property=\"og:description\" content=\"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30809\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-28T03:20:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-28T03:20:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots\",\"datePublished\":\"2025-03-28T03:20:45+00:00\",\"dateModified\":\"2025-03-28T03:20:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809\"},\"wordCount\":220,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2801-png.webp\",\"keywords\":[\"Finanical Reports\",\"HKG: 0853\",\"HKG: 2252\",\"MicroPort MedBot\",\"MicroPort Scientific\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30809#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30809\",\"name\":\"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2801-png.webp\",\"datePublished\":\"2025-03-28T03:20:45+00:00\",\"dateModified\":\"2025-03-28T03:20:46+00:00\",\"description\":\"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30809\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2801-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2801-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30809#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots - Insight, China's Pharmaceutical Industry","description":"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30809","og_locale":"en_US","og_type":"article","og_title":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots","og_description":"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.","og_url":"https:\/\/flcube.com\/?p=30809","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-28T03:20:45+00:00","article_modified_time":"2025-03-28T03:20:46+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30809#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30809"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots","datePublished":"2025-03-28T03:20:45+00:00","dateModified":"2025-03-28T03:20:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30809"},"wordCount":220,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=30809#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","keywords":["Finanical Reports","HKG: 0853","HKG: 2252","MicroPort MedBot","MicroPort Scientific"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30809#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30809","url":"https:\/\/flcube.com\/?p=30809","name":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=30809#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=30809#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","datePublished":"2025-03-28T03:20:45+00:00","dateModified":"2025-03-28T03:20:46+00:00","description":"Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) revealed its 2024 financial performance, recording RMB257 million (USD35 million) in revenues, a 146% year-on-year (YOY) increase. This growth was driven by the commercialization of the Toumai Laparoscopic Surgical Robot and SkyWalker Orthopedic Surgical Robot both domestically and internationally. Despite the revenue surge, the company reported an annual loss of RMB647 million (USD89 million), marking a significant YOY decline.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30809#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30809"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=30809#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","width":1080,"height":608,"caption":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30809#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2801-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30809"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30809\/revisions"}],"predecessor-version":[{"id":30811,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30809\/revisions\/30811"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/30810"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}